Practice Areas
Gregory Asciolla is a Partner in DiCello Levitt’s New York office, where he serves as Chair of the Firm’s Antitrust and Competition Litigation Practice. Greg focuses on representing businesses, public pension funds, and health and welfare funds in complex antitrust and commodities class actions. Greg currently represents clients in antitrust matters involving price-fixing, monopolization, benchmark and commodities manipulation, pay-for-delay agreements, and other anticompetitive practices. He also has represented, pro bono, three Ugandan LGBTQ clients seeking asylum in the U.S.
Greg has recovered billions on behalf of his clients and leads extensive investigations into potential anticompetitive conduct, often resulting in first-to-file cases. Prior to joining DiCello Levitt, Greg chaired a nationally-recognized antitrust practice group as a partner and oversaw significant growth in group size, leadership appointments, cases filed, investigations, and reputation. He also litigated and managed civil and criminal antitrust matters involving price-fixing, merger, and monopolization and conducted internal investigations and managed responses to government investigations on behalf of corporate targets as a partner at Morgan Lewis & Bockius LLP. Greg began his career as an attorney at the U.S. Department of Justice’s Antitrust Division, where he focused on anticompetitive conduct in the healthcare industry.
Professional Memberships
Greg is a member of the New York State Bar Association's Antitrust Law Section, and currently serves as co-chair of the antitrust and trade regulations committee of the New York County Lawyers' Association.
Publications
Greg's recent publications include "FDA Risk-Evaluation Guidance Unlikely to Help Generics" in Law360, and "Protecting Patents Through Tribal Sovereign Immunity: A Failed Experiment" in Antitrust Advisor.
